Review article · 2026
Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress
Nature Reviews Drug Discovery · Published 9 November 2026 · DOI 10.1038/s41573-026-01552-x
In brief
“Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress” is a 2026 review article by Bridget P. Keenan and 3 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 204
- Authors
- 4
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Keenan, B. P., Killebrew, J. R., Hollenbaugh, D. L., & Fong, L. H. (2026). Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01552-x
MLA 9
Keenan, Bridget P., et al. “Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress.” Nature Reviews Drug Discovery, 2026. https://doi.org/10.1038/s41573-026-01552-x.
Chicago
Keenan, Bridget P., Justin R Killebrew, Diane L. Hollenbaugh, and Lawrence H. Fong. 2026. “Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress.” Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01552-x.
Harvard
Keenan, B. P. et al. (2026) ‘Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress’, Nature Reviews Drug Discovery. doi:10.1038/s41573-026-01552-x.
IEEE
B. P. Keenan, J. R. Killebrew, D. L. Hollenbaugh, and L. H. Fong, “Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress,” Nature Reviews Drug Discovery, 2026, doi: 10.1038/s41573-026-01552-x.
BibTeX
@article{keenan2026conditional,
title = {{Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress}},
author = {Keenan, Bridget P. and Killebrew, Justin R and Hollenbaugh, Diane L. and Fong, Lawrence H.},
journal = {Nature Reviews Drug Discovery},
year = {2026},
doi = {10.1038/s41573-026-01552-x},
url = {https://doi.org/10.1038/s41573-026-01552-x}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- cancer immunotherapy
- tumor microenvironment
- immune-related adverse events
- cytokine release syndrome
- tumor accumulation
- immune checkpoint inhibitors
- therapeutic window
- clinical trials
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Keenan, B. P., Killebrew, J. R., Hollenbaugh, D. L., & Fong, L. H. (2026). Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-026-01552-x
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Bridget P. Keenan, Justin R Killebrew, Diane L. Hollenbaugh, Lawrence H. Fong.
What is the DOI of this paper?
10.1038/s41573-026-01552-x, permanently at https://doi.org/10.1038/s41573-026-01552-x. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.